Ruize Health key facts
as of Oct 2026- Operator of an online pharmacy marketplace designed for purchasing prescription and over-the-counter medicines.
- Ruize Health is valued at approximately $10.8M as of Oct 2026 (last reported valuation).
- It has raised $1.4M; the latest was Early Stage VC in Mar 2026.
- Notable investors include Marathon Venture Partners, China Life Reinsurance Company, Cenova Capital, Guangzhou Yaobang Information Technology, Yaoshibang.
- Status: Privately Held (backing).
Ruize Health's last reported valuation, Feb 2024. Nothing priced has surfaced since.
- ·Watch Ruize Health: the Monday email on marks, rounds and moves
Ruize Health funding rounds
No funding rounds for Ruize Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ruize Health valuation
Ruize Health's last reported valuation was $10.8 million in Feb 2024. No priced round, secondary trade or fund mark has surfaced since.
Ruize Health investors
5 investors are on record for Ruize Health, including Marathon Venture Partners, China Life Reinsurance Company, Cenova Capital and Guangzhou Yaobang Information Technology.
About Ruize Health
Operator of an online pharmacy marketplace designed for purchasing prescription and over-the-counter medicines. The company provides curated assortments and transparent pricing, enabling consumers with convenient purchase and delivery solutions.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2023
- Website
- ruizehealth.com.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.